The role of cardiovascular magnetic resonance (CMR) imaging in the field of cardio-oncology is rapidly growing. However, many who practice CMR are not educated in the field of cardio-oncology and the indications for CMR use in these patients. Following this activity learns will be able to recognize concerns are for cardiotoxicity that can be identified by CMR, the optimal CMR acquisition protocols for identification of cardiotoxicity are, and the optimal CMR interpretation protocols are for a CMR performed for cardiotoxicity evaluation..
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Attend the sessions in full for which credit is sought
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
The planners and faculty for this activity did not have any relevant relationships to disclose.
Disclosure of Commercial Support
SCMR received no funding to support this activity.
- Manning G. et al. Science 2002 298(5600) 1912-34
- Plana et al. J Am Soc Echocardiogr 2014;27:911-39
- Thavendiranathan et al J Am Coll Cardiol. 2013 Jan 8;61(1):77-84
- Sawaya et al Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603
- Negishi et al J Am Soc Echocardiogr. 2013 May;26(5):493-8
- Barac A et al JACC 2015;65(25):2739
- Jain V, Barac A. Curr Treat Options Cardio Med 2017
- Johnson DB et al NEJM 2016;375:1749
- Kenigsberg B, Barac A JACC Heart Failure in press 2018
- Gulati G et al Eur Heart 2016
- Pituskin E et al J Clin Oncol 2016
- NEJM 2016;375:15
- JACC 2016;67:2364
- Messroghli et al JCMR 2017